Yaogu Pharmaceutical

Yaogu Pharmaceutical is a China-based biotechnology company primarily focused on the research and development of innovative small molecule drugs for metabolic diseases. Located in the Zhangjiang Hi-Tech Park, often referred to as China's Pharma Valley, the company leverages its proximity to a dense ecosystem of life science research to advance its internal pipeline. Its primary therapeutic focus includes treatments for type 2 diabetes and other metabolic syndromes, with a particular emphasis on GLP-1 receptor agonists and DPP-4 inhibitors. In addition to its proprietary drug discovery efforts, the company provides pharmaceutical technology services and contract research support to the broader industry.